Champions Oncology (CSBR) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Champions Oncology (CSBR) over the last 16 years, with Q4 2025 value amounting to $8.5 million.
- Champions Oncology's Cash & Current Investments rose 20922.29% to $8.5 million in Q4 2025 from the same period last year, while for Oct 2025 it was $8.5 million, marking a year-over-year increase of 20922.29%. This contributed to the annual value of $9.8 million for FY2025, which is 27375.86% up from last year.
- As of Q4 2025, Champions Oncology's Cash & Current Investments stood at $8.5 million, which was up 20922.29% from $10.3 million recorded in Q3 2025.
- In the past 5 years, Champions Oncology's Cash & Current Investments registered a high of $11.6 million during Q1 2023, and its lowest value of $2.6 million during Q2 2024.
- For the 5-year period, Champions Oncology's Cash & Current Investments averaged around $6.7 million, with its median value being $6.5 million (2021).
- Per our database at Business Quant, Champions Oncology's Cash & Current Investments tumbled by 7412.53% in 2024 and then skyrocketed by 27375.86% in 2025.
- Over the past 5 years, Champions Oncology's Cash & Current Investments (Quarter) stood at $4.8 million in 2021, then skyrocketed by 125.54% to $10.8 million in 2022, then crashed by 49.08% to $5.5 million in 2023, then crashed by 50.05% to $2.8 million in 2024, then surged by 209.22% to $8.5 million in 2025.
- Its Cash & Current Investments stands at $8.5 million for Q4 2025, versus $10.3 million for Q3 2025 and $9.8 million for Q2 2025.